Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights
  • Choose License Type

Global Embolization Market, by Product Type (Particles (Radioembolization Spheres, Drug-eluting Beads, Microspheres (or Blands beads, without drug), and PVA particles (Polyvinyl Alcohol), Liquid Embolic, Plugs, and Coils), by Indication (Hemorrage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor (Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous embolization (incl. Varicocele for ex), and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,433.6 million in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Researchers and key players operating in the embolization market are focusing on development of innovative embolization products for the treatment of various chronic diseases such as tumor, hemorrhage and others, which is expected to provide lucrative opportunities to the market players to launch their novel products in the market and to increase their product portfolio and geographical footprint globally.  

For instance, in October 2020, Keystone Heart, LTD., a medical devices company, announced completion of the first worldwide commercial case using its TriGUARD 3 Cerebral Embolic Protection (CEP) device. The Pieter Stella, M.D., assistant professor from Medical Department of Cardiology, at UMC Utrecht in the Netherlands, successfully performed the transcatheter aortic valve implantation (TAVI), utilizing the TriGUARD 3 device, which is designed to minimize the risk of cerebral damage during trans-catheter heart procedures.

Global Embolization Market– Impact of Coronavirus (Covid-19) Pandemic

Embolization is the minimally invasive procedure, in which the occlusion of the selective blood vessels are blocked by introducing the embolic agents such as embolic coils, plugs, drug eluting beads, and others. The embolization procedures have wide applications such as in gastrointestinal bleeding, varicocele, cerebral aneurysm, cancers (liver cancer and kidney cancer), and others. Moreover, patients suffering from cancers such as kidney cancer, liver cancer, and others are more susceptible to get affected by the COVID-19. Moreover, the COVID-19 has impacted the activity of embolization procedures carried out in hospitals, as hospitals are converting their operating rooms and radiology centers into COVID-19 centers to accommodate the large number of patients with respiratory distress related to COVID-19 infection.

The governments of various countries are focusing on safety measures, while performing critical emergency interventions such as embolization procedures to treat hemorrhage effectively in the COVID-19 pandemic, and thus they are focusing on implementation of various guidelines during the treatment and management of cancer patients.

For instance, according to the Cardiovascular and Interventional Radiology journal 2020, the World Health Organization announced that several emergency interventional procedures such as embolization procedures are used for the treatment of various diseases such as hemorrage , liver cancer, kidney cancer, and others should be performed by the healthcare professional and radiologist during COVID-19 pandemic and also stated some safety measures while performing the interventional procedures

Browse 206 Market Data Tables and 56 Figures spread through 410 Pages and in-depth TOC on “Embolization Market”- Global Forecast to 2027, by Product Type (Particles (Radioembolization Spheres, Drug-eluting Beads, Microspheres (or Blands beads, without drug) and PVA particles (Polyvinyl Alcohol)), Liquid Embolic, Plugs, and Coils), by Indication (Hemorrage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor (Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous embolization (incl. Varicocele for ex), and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in the Global Embolization Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/embolization-market-4473

Researchers and key players operating in the market are focusing on development of low cost treatment options for the treatment of cancer, which will provide lucrative opportunity to market players to launch their innovative products in the market and help to increase their market share.

For instance, in July 2019, researchers from the Johns Hopkins University developed low cost reusable cryoablation device for the treatment of breast cancer. This device uses carbon dioxide and works by freezing cancer cells. This device will be easily affordable and available in low and middle income countries such as Bangladesh, Nigeria and others for the treatment of breast cancer. This device is under development and research team tested their tool in three experiments to ensure it could remain cold enough in conditions similar to the human breast and successfully kill tumor tissue.

Key Takeaways of the Global Embolization Market:

  • The global embolization market is expected to exhibit a CAGR of 8.1% over the forecast period, owing to increasing approval of products by regulatory authority. For instance, in 2019, Terumo Corporation received European Commission (CE) mark approval for its QuiremScout (Microspheres) for Selective internal radiation therapy (SIRT).
  • Among product type, particles segment accounted for the largest market share in 2020, owing to academic institutes and research institutes increasingly focusing on the research and development of radio embolization techniques for the treatment of cancers. For instance, in August 2020, the Northwestern University, Chicago, U.S. announced they are focusing on the R&D of radioembolization for the treatment of prostate cancers. The university also stated that it is a novel treatment, which adopts radioembolization procedures in prostatic artery embolization (PAE) and musculoskeletal embolization.
  • Key players operating in the global embolization market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly Subscribe for our latest news & articles.